Melatonin Pharmacokinetics Following Oral Administration in Preterm Neonates.

about

Extended Combined Neonatal Treatment With Erythropoietin Plus Melatonin Prevents Posthemorrhagic Hydrocephalus of Prematurity in Rats

P2860

Q57491952-DF2B90AF-7EC1-4A89-9C90-2B5B6101A460

P2860

Melatonin Pharmacokinetics Following Oral Administration in Preterm Neonates.

Item

http://www.wikidata.org/entity/Q47940557

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Melatonin Pharmacokinetics Following Oral Administration in Preterm Neonates.

@en

Melatonin Pharmacokinetics Following Oral Administration in Preterm Neonates.

@nl

type

Item

label

Melatonin Pharmacokinetics Following Oral Administration in Preterm Neonates.

@en

Melatonin Pharmacokinetics Following Oral Administration in Preterm Neonates.

@nl

prefLabel

Melatonin Pharmacokinetics Following Oral Administration in Preterm Neonates.

@en

Melatonin Pharmacokinetics Following Oral Administration in Preterm Neonates.

@nl

P1476

Melatonin Pharmacokinetics Following Oral Administration in Preterm Neonates

@en

P2093

Eloisa Gitto

http://www.w3.org/2001/XMLSchema#string

Fabrizio Proietti

http://www.w3.org/2001/XMLSchema#string

Giuseppe Buonocore

http://www.w3.org/2001/XMLSchema#string

Lucia Marseglia

http://www.w3.org/2001/XMLSchema#string

Marco Rocchi

http://www.w3.org/2001/XMLSchema#string

Mariangela Longini

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis

A simple practice guide for dose conversion between animals and human

Protective role of melatonin in neonatal diseases

The ontogeny of human drug-metabolizing enzymes: phase II conjugation enzymes and regulatory mechanisms

Long-term neurodevelopmental outcomes after preterm birth

PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel.

An assessment of the antioxidant and the antiamyloidogenic properties of melatonin: implications for Alzheimer's disease.

Effects of melatonin treatment in septic newborns.

Developmental pharmacology--drug disposition, action, and therapy in infants and children.

Plasma concentrations of melatonin in man following oral absorption of different preparations

P31

scholarly article

P356

10.3390/MOLECULES22122115

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Walter Balduini

Silvia Carloni

Gabriella D'Angelo

P577

2017-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29194416

http://www.w3.org/2001/XMLSchema#string

P921

melatonin

P932

6149762

http://www.w3.org/2001/XMLSchema#string

Melatonin Pharmacokinetics Following Oral Administration in Preterm Neonates.

about

P2860

P2860

Melatonin Pharmacokinetics Following Oral Administration in Preterm Neonates.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932